Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Michael Perusich, BS, MS, DC, LMn, DICCP, FICC
Dr. Michael Perusich, is a solutions-focused advisor with more than 25 years of success across the health care and consulting industries. His broad areas of expertise include coaching, training, content development and motivational speaking. He is the CEO & managing partner for Kats Consultants, LLC., offering a unique platform of business knowledge for today's health care entrepreneur.